Coloplast goes for the throat

The third-largest medtech acquisition of the year happened with little fanfare this week. Coloplast spent €2.2bn ($2.5bn) on Atos Medical, a maker of devices for tracheostomy and laryngectomy patients, knocking ICU Medical’s purchase of Smiths Group’s medical business into fourth place. The Sweden-based Atos occupies more than 80% of the laryngectomy market, according to Coloplast, with sales last year of SEK2.2bn ($253m). Coloplast, which had a difficult 2020 as the pandemic hit its hospital business, has recovered surprisingly well, with its stock up 23% year to date. Its sales are forecast to grow at a respectable annual rate of 8% to 2026, Evaluate Medtech data show; perhaps, with the inclusion of Atos’s technology, they will grow faster still. 

Top 5 medtech M&A of 2021
Announcement date Acquirer Target Value ($bn) Focus
Sep 1 Baxter International Hill-Rom 10.5 General hospital & healthcare supply; healthcare IT
Jan 12 Steris Cantel Medical 4.6 Endoscopy; general & plastic surgery; nephrology
Nov 8 Coloplast  Atos Medical 2.5 Ear, nose & throat; general hospital & healthcare supply
Sep 8 ICU Medical Smiths Medical (subunit of Smiths Group) 2.4 Anaesthesia & respiratory; patient monitoring
Mar 12 Roche Genmark Diagnostics 1.8 In vitro diagnostics
Note: excludes Spac deals. Source: Evaluate Medtech & company release. 

Share This Article